Dr Reddys Laboratories (RDY) Asset Utilization Ratio (2009)
Dr Reddys Laboratories (RDY) posted quarterly Asset Utilization Ratio of 0.98 for Q4 2009, up 9.52% quarter-over-quarter from 0.89 in Q3 2009.
Dr Reddys Laboratories (RDY) Asset Utilization Ratio (2009) Analysis & Trends
Dr Reddys Laboratories' Asset Utilization Ratio history runs 1 years deep, the most recent figure standing at 0.98 for Q4 2009.
- In Q4 2009, Asset Utilization Ratio changed N/A year-over-year to 0.98; the TTM figure through Dec 2009 stood at 0.98 (changed N/A YoY), while the FY2026 annual figure was 0.6, down 18.05% from the prior year.
- Asset Utilization Ratio for Q4 2009 stood at 0.98, up from 0.89 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.98 in Q4 2009, with the low at 0.89 in Q3 2009.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 0.98 |
| Sep 30, 2009 | 0.89 |